Symbol="XLO"
AssetType="Common Stock"
Name="Xilio Development Inc"
Description="Xilio Therapeutics, Inc., a biotechnology company, designs immunotherapies to improve the immune systems of cancer patients. The company is headquartered in Waltham, Massachusetts."
CIK="1840233"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="828 WINTER STREET, WALTHAM, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="75460000"
EBITDA="-89545000"
PERatio="None"
PEGRatio="None"
BookValue="3.09"
DividendPerShare="0"
DividendYield="0"
EPS="-3.27"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.371"
ReturnOnEquityTTM="-0.714"
RevenueTTM="0"
GrossProfitTTM="-56774000"
DilutedEPSTTM="-3.27"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="9.75"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="0.518"
EVToRevenue="-"
EVToEBITDA="0.64"
Beta="None"
num_52WeekHigh="4.92"
num_52WeekLow="1.95"
num_50DayMovingAverage="2.877"
num_200DayMovingAverage="2.847"
SharesOutstanding="27440000"
DividendDate="None"
ExDividendDate="None"
symbol="XLO"
open="2.75"
high="2.94"
low="2.73"
price="2.85"
volume="31685.00"
latest_trading_day="2023-07-21"
previous_close="2.75"
change="0.10"
change_percent="3.6364%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="54"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="46"
Volume_recent_avg="22560"
Change_recent_avg="-0.01"
Delta_recent_avg="0.23"
Variance_recent_avg="0.11"
Change_ratio_recent_avg="-0.28"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="46"
Aroon_momentum_negative="54"
image_negative_thumbnail_id_1="161"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0015.jpeg"
image_negative_thumbnail_id_2="141"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0035.jpeg"
image_neutral_thumbnail_id_1="538"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0061.jpeg"
image_neutral_thumbnail_id_2="595"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0004.jpeg"
image_positive_thumbnail_id_1="998"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0160.jpeg"
image_positive_thumbnail_id_2="977"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0139.jpeg"
image_professor_thumbnail_id_1="1173"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0007.jpeg"
image_professor_thumbnail_id_2="1186"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0020.jpeg"
